NPS Intelligence (beta)

Disclosed NPS & retention by vertical

—
Latest disclosed NPS
no score published
1
NPS entries
0 with a number
2021
Years covered
1 entries in all

In their words

“They're able to sleep through the night with really good blood sugar control. And we measure things like net promoter score on a product level as well., and it's up about tenfold from what we saw – experienced over 670G. So, a very, very big improvement.”
— Sean Salmon, EVP and President, Cardiovascular Portfolio and Diabetes Operating Unit, Medtronic plc · Earnings call, Q3 2021 · 23 Feb 2021 · NI-2FC14FB

NPS disclosures (1)

Search the database →

23 Feb 2021
NPSProgram

They're able to sleep through the night with really good blood sugar control. And we measure things like net promoter score on a product level as well., and it's up about tenfold from what we saw – experienced over 670G. So, a very, very big improvement.

— Sean Salmon, EVP and President, Cardiovascular Portfolio and Diabetes Operating Unit, Medtronic plc · Earnings call, Q3 2021 · 23 Feb 2021 · NI-2FC14FB
Earnings call, Q3 2021 ↗

Retention disclosures (0)

Open in the retention database →

No retention figures yet.

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.